Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$11,744,542
+$2,310,914 QoQ
Shares Held
46,672
+7.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#847
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 65%
Shared 35%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Belpointe Asset Management LLC holds $43,294,431 across 10 Drug Manufacturers - General names. ABBV ranks #1 (27.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
46,672 | $11,744,542 | |
| 2 | LLY |
ELI LILLY & Co
|
7,399 | $8,874,583 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
125,071 | $7,206,591 | |
| 4 | JNJ |
Johnson & Johnson
|
16,266 | $4,131,076 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,259 | $3,888,281 | |
| 6 | PFE |
Pfizer Inc
|
156,552 | $3,769,772 | |
| 7 | AMGN |
Amgen Inc
|
6,723 | $2,434,532 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,464 | $816,661 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,744,542 | 46,672 | Shares | Other | 2026-07-31 | |
| 2026-03-31 | $9,433,628 | 43,375 | Shares | Other | 2026-04-28 | |
| 2025-12-31 | $8,119,392 | 35,535 | Shares | Other | 2026-01-27 | |
| 2025-09-30 | $8,253,937 | 35,648 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $6,131,028 | 33,030 | Shares | Other | 2025-07-22 | |
| 2025-03-31 | $7,254,630 | 34,625 | Shares | Other | 2025-05-20 | |
| 2024-12-31 | $7,024,125 | 39,528 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $7,853,779 | 39,770 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $6,467,676 | 37,708 | Shares | Other | 2024-08-02 | |
| 2024-03-31 | $6,682,705 | 36,698 | Shares | Other | 2024-05-08 | |
| 2023-12-31 | $5,354,213 | 34,550 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $5,089,951 | 34,147 | Shares | Other | 2023-11-15 | |
| 2023-06-30 | $4,469,802 | 33,176 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $9,347,369 | 58,652 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $9,861,118 | 61,018 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $7,544,078 | 56,211 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,012,890 | 45,788 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $9,027,581 | 55,688 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $9,112,149 | 67,298 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $7,100,434 | 65,824 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,044,262 | 53,660 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $5,521,167 | 51,018 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $6,168,089 | 57,565 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,766,647 | 54,420 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,209,786 | 63,249 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $2,398,994 | 31,487 | Shares | Sole | 2020-07-20 | |
| No filing history on record for this holder in this stock. | ||||||